Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
32.35
-0.34 (-1.04%)
Dec 5, 2025, 4:00 PM EST - Market closed
Global Medical REIT Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Global Medical REIT stock have an average target of 40.5, with a low estimate of 40 and a high estimate of 41. The average target predicts an increase of 25.19% from the current stock price of 32.35.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Global Medical REIT stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Maintains $45 → $41 | Hold | Maintains | $45 → $41 | +26.74% | Nov 11, 2025 |
| JMP Securities | JMP Securities | Hold → Buy Upgrades $40 | Hold → Buy | Upgrades | $40 | +23.65% | Oct 13, 2025 |
| Baird | Baird | Hold Maintains $50 → $45 | Hold | Maintains | $50 → $45 | +39.10% | May 8, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 12, 2025 |
| Berenberg | Berenberg | Strong Buy Initiates $59 | Strong Buy | Initiates | $59 | +81.61% | Oct 18, 2024 |
Financial Forecast
Revenue This Year
149.15M
from 138.76M
Increased by 7.49%
Revenue Next Year
153.89M
from 149.15M
Increased by 3.18%
EPS This Year
0.28
from 0.06
Increased by 353.34%
EPS Next Year
0.12
from 0.28
Decreased by -58.54%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 154.6M | 161.6M | ||
| Avg | 149.2M | 153.9M | ||
| Low | 140.1M | 146.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 11.4% | 8.4% | ||
| Avg | 7.5% | 3.2% | ||
| Low | 1.0% | -2.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.37 | 0.42 | |
| Avg | 0.28 | 0.12 | |
| Low | 0.15 | -0.12 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 497.6% | 50.6% | |
| Avg | 353.3% | -58.5% | |
| Low | 139.0% | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.